Skip to main content

CORRECTION article

Front. Oncol., 23 January 2023
Sec. Surgical Oncology

Zhen LiuZhen Liu1Yichunzi ZhangYichunzi Zhang2Han YinHan Yin3Xiuzhu GengXiuzhu Geng3Sishang LiSishang Li3Jinrong ZhaoJinrong Zhao4Ziyang ZengZiyang Zeng1Xin YeXin Ye1Jianchun YuJianchun Yu1Fan Feng*Fan Feng5*Weiming Kang*Weiming Kang1*
  • 1Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • 2National Health Commission (NHC) Key Laboratory of Systems Biology of Pathogens and Christophe Mérieux Laboratory, Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • 3Ministry of Health (MOH) Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • 4Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • 5Division of Digestive Surgery, Xijing Hospital of Digestive Diseases, The Air Force Medical University, Xi’an, China

A Corrigendum on
Comparison of prognosis between microscopically positive and negative surgical margins for primary gastrointestinal stromal tumors: A systematic review and meta-analysis.

By Liu Z, Zhang Y, Yin H, Geng X, Li S, Zhao J, Zeng Z, Ye X, Yu J, Feng F, Kang W (2022) Front. Oncol. 12:679115. doi: 10.3389/fonc.2022.679115

Incorrect Affiliation

In the published article, there was an error in affiliation 1. Instead of “Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China,” it should be deleted.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: gastrointestinal stromal tumor, R1 margin, Imatinib, prognosis, meta-analysis

Citation: Liu Z, Zhang Y, Yin H, Geng X, Li S, Zhao J, Zeng Z, Ye X, Yu J, Feng F and Kang W (2023) Corrigendum: Comparison of prognosis between microscopically positive and negative surgical margins for primary gastrointestinal stromal tumors: A systematic review and meta-analysis. Front. Oncol. 12:1110168. doi: 10.3389/fonc.2022.1110168

Received: 28 November 2022; Accepted: 29 November 2022;
Published: 23 January 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Liu, Zhang, Yin, Geng, Li, Zhao, Zeng, Ye, Yu, Feng and Kang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Weiming Kang, a2FuZ3dlaW1pbmdAMTYzLmNvbQ==; Fan Feng, c3VyZ2VvbmZlbmdmYW5AMTYzLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.